Developments in biotechnology

Kevan M.A. Gartland, Munis Dundar, Tommaso Beccari, Mariapia Viola-Magni

    Research output: Contribution to journalMeeting abstract

    Abstract

    Recent developments throughout biotechnology are demonstrating how technology is beginning to converge, providing multiple potential benefits across biomedicine and the life sciences. From the rapidly expanding growth in genome editing using CRISPR, ZFNs and TALENS tools, leading to numerous applications from non-viable human embryos to agriculture, e.g. mushrooms, this disruptive technology shows every sign of revolutionising biotechnology. Synthetic biology is making major advances and is likely to lead to novel bioprocesses and products, as well as providing new insights into growth, development and the ‘minimal organism’. The emergence of Three-Parent Baby births may one day influence human evolution, through genetic and metabolic load effects. Other key developments include the use and availability of personalised and consumer-led exome, microbiome and genome information, converging with artificial intelligence techniques, and the emergence of single cell technologies to monitor and control gene expression. These developments will impact on business biotechnology and lead to changes in the structure of the biotechnology industry.
    Original languageEnglish
    Pages (from-to)57
    Number of pages1
    JournalJournal of Biotechnology
    Volume256
    Issue numberSupplement
    Early online date16 Aug 2017
    DOIs
    Publication statusPublished - 30 Aug 2017

    Fingerprint

    Biotechnology
    Technology
    Clustered Regularly Interspaced Short Palindromic Repeats
    Genetic Load
    Genes
    Synthetic Biology
    Exome
    Biological Science Disciplines
    Agaricales
    Artificial Intelligence
    Microbiota
    Agriculture
    Growth and Development
    Gene expression
    Artificial intelligence
    Industry
    Embryonic Structures
    Lead
    Availability
    Parturition

    Keywords

    • biotechnology
    • gene editing
    • biomedicine

    Cite this

    Gartland, K. M. A., Dundar, M., Beccari, T., & Viola-Magni, M. (2017). Developments in biotechnology. Journal of Biotechnology, 256(Supplement), 57. https://doi.org/10.1016/j.jbiotec.2017.06.024
    Gartland, Kevan M.A. ; Dundar, Munis ; Beccari, Tommaso ; Viola-Magni, Mariapia. / Developments in biotechnology. In: Journal of Biotechnology. 2017 ; Vol. 256, No. Supplement. pp. 57.
    @article{832698bf2fac4d508f87b0944ddea7cf,
    title = "Developments in biotechnology",
    abstract = "Recent developments throughout biotechnology are demonstrating how technology is beginning to converge, providing multiple potential benefits across biomedicine and the life sciences. From the rapidly expanding growth in genome editing using CRISPR, ZFNs and TALENS tools, leading to numerous applications from non-viable human embryos to agriculture, e.g. mushrooms, this disruptive technology shows every sign of revolutionising biotechnology. Synthetic biology is making major advances and is likely to lead to novel bioprocesses and products, as well as providing new insights into growth, development and the ‘minimal organism’. The emergence of Three-Parent Baby births may one day influence human evolution, through genetic and metabolic load effects. Other key developments include the use and availability of personalised and consumer-led exome, microbiome and genome information, converging with artificial intelligence techniques, and the emergence of single cell technologies to monitor and control gene expression. These developments will impact on business biotechnology and lead to changes in the structure of the biotechnology industry.",
    keywords = "biotechnology, gene editing, biomedicine",
    author = "Gartland, {Kevan M.A.} and Munis Dundar and Tommaso Beccari and Mariapia Viola-Magni",
    note = "Author confirmed abstract not article, changed template ET 26-1-18 No acceptance date required",
    year = "2017",
    month = "8",
    day = "30",
    doi = "10.1016/j.jbiotec.2017.06.024",
    language = "English",
    volume = "256",
    pages = "57",
    journal = "Journal of Biotechnology",
    issn = "0168-1656",
    publisher = "Elsevier B.V.",
    number = "Supplement",

    }

    Gartland, KMA, Dundar, M, Beccari, T & Viola-Magni, M 2017, 'Developments in biotechnology', Journal of Biotechnology, vol. 256, no. Supplement, pp. 57. https://doi.org/10.1016/j.jbiotec.2017.06.024

    Developments in biotechnology. / Gartland, Kevan M.A.; Dundar, Munis; Beccari, Tommaso; Viola-Magni, Mariapia.

    In: Journal of Biotechnology, Vol. 256, No. Supplement, 30.08.2017, p. 57.

    Research output: Contribution to journalMeeting abstract

    TY - JOUR

    T1 - Developments in biotechnology

    AU - Gartland, Kevan M.A.

    AU - Dundar, Munis

    AU - Beccari, Tommaso

    AU - Viola-Magni, Mariapia

    N1 - Author confirmed abstract not article, changed template ET 26-1-18 No acceptance date required

    PY - 2017/8/30

    Y1 - 2017/8/30

    N2 - Recent developments throughout biotechnology are demonstrating how technology is beginning to converge, providing multiple potential benefits across biomedicine and the life sciences. From the rapidly expanding growth in genome editing using CRISPR, ZFNs and TALENS tools, leading to numerous applications from non-viable human embryos to agriculture, e.g. mushrooms, this disruptive technology shows every sign of revolutionising biotechnology. Synthetic biology is making major advances and is likely to lead to novel bioprocesses and products, as well as providing new insights into growth, development and the ‘minimal organism’. The emergence of Three-Parent Baby births may one day influence human evolution, through genetic and metabolic load effects. Other key developments include the use and availability of personalised and consumer-led exome, microbiome and genome information, converging with artificial intelligence techniques, and the emergence of single cell technologies to monitor and control gene expression. These developments will impact on business biotechnology and lead to changes in the structure of the biotechnology industry.

    AB - Recent developments throughout biotechnology are demonstrating how technology is beginning to converge, providing multiple potential benefits across biomedicine and the life sciences. From the rapidly expanding growth in genome editing using CRISPR, ZFNs and TALENS tools, leading to numerous applications from non-viable human embryos to agriculture, e.g. mushrooms, this disruptive technology shows every sign of revolutionising biotechnology. Synthetic biology is making major advances and is likely to lead to novel bioprocesses and products, as well as providing new insights into growth, development and the ‘minimal organism’. The emergence of Three-Parent Baby births may one day influence human evolution, through genetic and metabolic load effects. Other key developments include the use and availability of personalised and consumer-led exome, microbiome and genome information, converging with artificial intelligence techniques, and the emergence of single cell technologies to monitor and control gene expression. These developments will impact on business biotechnology and lead to changes in the structure of the biotechnology industry.

    KW - biotechnology

    KW - gene editing

    KW - biomedicine

    U2 - 10.1016/j.jbiotec.2017.06.024

    DO - 10.1016/j.jbiotec.2017.06.024

    M3 - Meeting abstract

    VL - 256

    SP - 57

    JO - Journal of Biotechnology

    JF - Journal of Biotechnology

    SN - 0168-1656

    IS - Supplement

    ER -

    Gartland KMA, Dundar M, Beccari T, Viola-Magni M. Developments in biotechnology. Journal of Biotechnology. 2017 Aug 30;256(Supplement):57. https://doi.org/10.1016/j.jbiotec.2017.06.024